tiprankstipranks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
NVCT
Nuvectis Pharma
RESEARCH TOOLSreports
Want to see NVCT full AI Analyst Report?

Nuvectis Pharma (NVCT) Income Statement

117 Followers

Nuvectis Pharma Income Statement

Last quarter (Q4 2025), Nuvectis Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Nuvectis Pharma's net income was $-7.31M. See Nuvectis Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 27.57M$ 19.85M$ 22.90M$ 19.23M$ 12.89M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -27.57M$ -19.00M$ -22.90M$ -19.23M$ -12.89M
Operating Income
$ -27.57M$ -19.85M$ -22.90M$ -19.23M$ -12.89M
Other Income/Expenses
$ 1.13M$ 847.00K$ 637.00K$ 149.00K$ 4.00K
Pretax Income
$ -26.44M$ -19.00M$ -22.26M$ -19.09M$ -12.89M
Net Income
$ -26.44M$ -19.00M$ -22.26M$ -19.09M$ -12.89M
Per Share Metrics
Basic EPS
$ -1.32$ -1.11$ -1.43$ -1.51$ -1.09
Diluted EPS
$ -1.32$ -1.11$ -1.43$ -1.51$ -1.09
Weighted Average Shares Outstanding
 21.81M 17.11M 15.56M 12.66M 12.72M
Weighted Average Shares Outstanding (Diluted)
 21.81M 17.11M 15.56M 12.66M 12.72M
Currency in USD

Nuvectis Pharma Earnings and Revenue History